Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Pfizer to invest over $1.26 billion in Irish jobs boost

Published 12/01/2022, 08:53 AM
Updated 12/01/2022, 10:17 AM
© Reuters. FILE PHOTO: Pfizer logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration/File Photo

© Reuters. FILE PHOTO: Pfizer logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration/File Photo

DUBLIN (Reuters) -Pfizer Inc plans to invest more than 1.2 billion euros ($1.26 billion) to expand manufacturing at its plant in Dublin, it said on Thursday, handing the Irish multinational sector a jobs boost at a time when major tech firms are laying off staff.

The move will lead to the creation of 400 to 500 new roles and double the capacity to produce key substances used in biological drugs at a new facility, which is due for completion in 2027, Pfizer (NYSE:PFE) said.

The U.S. drugmaker is already one of the largest foreign-owned employers in Ireland and its biggest single investment to date in the country will bring its staffing there to 5,500.

Ireland is hugely reliant on the multinationals that together employ more than 275,000 people, or one in nine workers, and account for a large chunk of the country's income and corporate taxes.

Many of the world's leading drugmakers have operations in Ireland and Pfizer's expansion follows a similar announcement by U.S. healthcare company Abbott Laboratories (NYSE:ABT) in August that it would add 1,000 new jobs.

Multinational jobs growth soared to record levels in the first half of this year, but since then a number of tech companies including Facebook parent Meta Platforms Inc (NASDAQ:META), Twitter and Stripe have laid off Irish staff as part of global cutbacks.

The state agency charged with attracting new companies to the country has said it expects multinational investment to weaken slightly next year.

However data this week showed that Ireland's unemployment rate fell slightly to 4.4% in November and remains near a 21-year-low amid a tight labour market.

© Reuters. FILE PHOTO: Pfizer logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration/File Photo

Pfizer, which last year began producing an ingredient for its COVID-19 vaccine at the facility in Dublin, said the new investment for non-COVID licensed and pipeline products will help to further expand the site's broad capabilities.

($1 = 0.9530 euros)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.